Quality Policy

Oncura’s vision is to lead the market by providing minimally invasive prostate cancer treatment options and to expand our portfolio to include additional products along the prostate disease management continuum.

Our goal is to champion the appropriate use of Brachytherapy and Cryotherapy as the treatments of choice for prostate cancer.

Our ongoing commitment is to developing innovations in minimally invasive prostate and kidney cancer care for patients and physicians. We view innovation as the key to entrepreneurial success. That’s why rigorous innovation management is a top priority for us.

We believe our first responsibility is to our customers and patients who use our products and services. In meeting their needs everything we do must be of high quality. We must constantly strive for continuous quality improvement and at the same time strive to reduce total costs in order to maintain reasonable prices.

We are responsible to our employees and we must respect their dignity and recognize their merit. All Oncura employees must feel free to make suggestions and complaints. There must be equal opportunity for employment, development and advancement for those qualified.

Our Final responsibility is to our stockholders. Our business must make a sound profit. When we operate according to established principles, the stockholders should realize a fair return.

James S. McGlone
President & CEO
Oncura, Inc.

Click here to download our Quality Policy in pdf format.